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Quantitative backscattered electron imagingTrace elements are chemical elements inminute quantities, which are known to accumulate in the bone. Cortical
and trabecular bones consist of bone structural units (BSUs) such as osteons and bone packets of different min-
eral content and are separated by cement lines. Previous studies investigating trace elements in bone lacked res-
olution and therefore very little is known about the local concentration of zinc (Zn), strontium (Sr) and lead (Pb)
in BSUs of human bone. We used synchrotron radiation induced micro X-ray ﬂuorescence analysis (SR μ-XRF) in
combinationwith quantitative backscattered electron imaging (qBEI) to determine the distribution and accumu-
lation of Zn, Sr, and Pb in human bone tissue.
Fourteen human bone samples (10 femoral necks and 4 femoral heads) from individuals with osteoporotic fem-
oral neck fractures aswell as fromhealthy individualswere analyzed. Fluorescence intensitymapswerematched
with BE images and correlated with calcium (Ca) content. We found that Zn and Pb had signiﬁcantly increased
levels in the cement lines of all samples compared to the surrounding mineralized bone matrix. Pb and Sr levels
were found to be correlated with the degree of mineralization. Interestingly, Zn intensities had no correlation
with Ca levels. We have shown for the ﬁrst time that there is a differential accumulation of the trace elements
Zn, Pb and Sr in BSUs of human bone indicating different mechanisms of accumulation.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Introduction
When tissue of living organisms is analyzed by highly sensitive
chemical analytic methods, speciﬁc chemical elements in very minute
quantities (bppm) can be found. These so called trace elements can be
essential and/or non-essential for the living organism [1]. However,
the role ofmany trace elements in tissues e.g. bone is poorly understood
[2]. Great efforts have been undertaken to determine the incorporated
amounts of various trace elements in bone [3,4]. Since in general the
chemical analysis is based on destructive methods, the information
about the spatial distribution of the trace elements within the tissue isdiation physics, Stadionallee 2,
dreas.roschger@osteologie.at
ter@osteologie.at
n@kit.edu (R. Simon),
eologie.at (P. Roschger),
c.at (C. Streli).
c. Open access under CC BY license.usually lost. Previous studies lacked spatial distribution and merely dif-
ferentiated between cortical and trabecular bone [5–10]. New develop-
ments in synchrotron radiation technology allow now analyzing in a
non-destructive way, spatially resolved trace elements like zinc (Zn),
strontium (Sr) and lead (Pb) in bone tissue. For example using synchro-
tron radiation induced confocal micro X-ray ﬂuorescence analysis (SR
μ-XRF)we found a highly speciﬁc accumulation of Pb and Zn in the tran-
sition zone betweenmineralized and nonmineralized articular cartilage
compared to subchondral bone [11,12]. Moreover this method is also
able to detect and map different elements simultaneously [13].
Zn, Sr and Pb are trace elements, present in sufﬁcient concentrations
in bone so they can be easily mapped with the multi-elemental SR
μ-XRF method. Zn is an important essential trace element in multiple
biological processes and a reduced intake may lead to chronic diseases
[14]. Zn is also present in bone tissue and it has been reported to play
an important role in bone metabolism [15–17]. Studies on the Zn levels
in different tissues revealed thatmost of it is present in bone and for this
reason Znmay be considered as an essential component of the calciﬁed
matrix [18,19]. Sr is likely a non-essential trace element, but in recent
years, studies have shown that Sr is able to inﬂuence bone turnover
[20] and has been applied in the form of strontium ranelate in
185B. Pemmer et al. / Bone 57 (2013) 184–193therapeutic treatment of osteoporosis. Sr is chemically very similar to
calcium (Ca), and can replace Ca, but still little is known about the role
of Sr in normal bone metabolism as well as in bone disorders. Pb is a
non-essential trace element and represents a highly toxic heavy metal.
One of the main threats to human health from heavy metals is associat-
ed with exposure to Pb. Exposure to Pb is associated with chronic dis-
eases in the nervous, hematopoietic, skeletal, renal and endocrine
systems [21,22]. Pb has been stated also as a potential risk factor for os-
teoporosis [23] and osteoarthritis [24]. Approximately 95% of the total
body Pb burden is stored in skeleton [25] indicating that the bone tissue
has a high capacity to accumulate and store Pb. In this context the bone
tissue seems to have also the function to keep down the serum levels of
such highly toxic elements.
Human bone is essentially composed of a non-homogeneous and
non-isotropic arrangement of mineralized collagen ﬁbrils. Cortical and
trabecular bones are formed by individual osteons and bone packets
(so called bone structural units— BSUs). They are produced at different
moments during the (re)modeling cycle by the coordinated activity of
bone cells, whereby the osteoblasts synthesize, secrete and deposit
the collagenous matrix, which then gradually mineralizes. Thus, each
BSU has a certain mineral content depending on the time of deposition
[26]. In general these BSUs are connected by a thin layer of mineralized
non-collagenous proteins, the so called cement line/layer produced
during the remodeling cycle [27]. Only very little data are available
regarding the detailed spatial distribution of trace elements within
such a bone tissue.
Thus, the aims of this study were to map the trace elements Zn, Sr
and Pb in bone tissue and to elucidate the following questions: i) is
there a differential accumulation pattern of Zn, Sr and Pb depending
on Ca content of mineralized bone matrix in the bone packets, osteons,
and interstitial bone? and ii) is the accumulation of Zn, Sr and Pb in
cement lines different from that of mineralized bone matrix? Taking
into account that the spot size of the confocal SR μ-XRF setup is about
5 times wider than thewidth of the cement lines themeasured intensi-
ties are actually a huge underestimate of the real levels of trace elements
in this region.
For this purpose we analyzed trabecular and cortical bones from
human femoral necks and heads using SR μ-XRF in combination
with quantitative backscattered electron imaging (qBEI). qBEI, a well
established and validatedmethod [28], was used to visualize theminer-
alized tissue with a spatial resolution of 1 μm per pixel, to quantify the
local bone mineral/Ca content and select the regions of interest for SR
μ-XRF measurements in the bone tissue.
Materials and methods
Bone samples
For this study bone samples from 14 postmenopausal women have
been analyzed: a) Femoral neck samples (n = 10) which had been
part of a former study [29,30] andwere kindly provided byN. Loveridge
(Department of Medicine, University of Cambridge, Cambridge). Five
of these samples were from patients suffering from an osteoporotic
femoral neck fracture and 5 sampleswere from forensic autopsies of in-
dividuals withoutmetabolic bone diseases agematchedwith that of os-
teoporotic fractures. The average age of these individualswas 81.5 years
ranging from 74 to 92 years. b) Femoral head samples (n = 4), which
were obtained during hip replacement surgery. The individuals suffered
an osteoporotic femoral neck fracture and were 60 to 80 years old with
an average age of 77.5 years. Measurements were performed in both
trabecular and cortical bone regions for the femoral neck samples and
only in the trabecular region for the femoral head samples resulting in
a total of 35 areas of about 500 μm × 650 μm. The term mineralized
bone matrix will describe both the osteons and the interstitial bone in
the osteonal bone region and bone packets in cancellous bone region.
To the best of our knowledge, none of the patients has been exposedto higher Pb concentrations than the natural levels in their living
areas. The study was in accordance with and approved by the local
ethics committee (Institutional Review Board of the Medical University
of Vienna).
Sample preparation
As already described in earlier publications [31,32], the samples
have been prepared as blocks of undecalciﬁed in polymethyl-
methacrylate (PMMA) embedded bone tissue. The femoral neck sam-
ples were cut in the transversal plane and the femoral head samples
perpendicular to the articular surface (frontal plane). The section sur-
faces were manufactured by grinding with sand paper and subse-
quently polishing with diamond suspension (3 and 1 μm grain size)
on a precision polishing device (PM5: Logitech Ltd., Glasgow, UK) or
by milling with a diamond ultra miller (SP2600: Leica Microsystems
GmbH,Wetzlar, Germany). The entire embedding and surface prepara-
tion procedure was tested to be free of detectable Zn, Sr and Pb
contaminations.
qBEI
Quantitative backscattered electron imaging (qBEI) is a validated
technique to visualize and quantify the calcium (Ca) concentration dis-
tribution in bone based on the backscattering of electrons from the sam-
ple surface in a scanning electron microscope (SEM). Areas with bright
gray levels reﬂectmatrix with high Ca content, whereas areaswith dark
gray levels indicate low Ca content. Cement lines, the transition zones
between different bone packets and osteons usually show a higher
mineral content than the adjacent mineralized bone matrix [26,33].
More details on the qBEI method can be found elsewhere [31,34].
A SEM (DSM 962, Zeiss, Oberkochen, Germany) was employed to
acquire qBEI images using 20 keV electrons leading to an information
depth of about 1.5 μm [35]. Images at different magniﬁcations 12-fold
for overviews and 200-fold (pixel resolution of about 1 × 1 μm2) were
obtained to select and deﬁne the region of interest (ROI) in bone for
SR-μ-XRF analysis similar to a study done previously [32]. Especially
areas (bone packets, osteons) containing mineralized bone matrix
with different degrees of mineralization have been selected.
SR-μ-XRF
The properties of synchrotron radiation (SR) including high photon
ﬂux, natural collimation, polarization and the possibility to select
the energy of the primary photons enabled sensitivities up to the
femtogram range and a high spatial resolution in the micrometer
range. In previous studies, the combination of a confocal geometry
and SR allowed the analysis of trace elements in bone and articular
cartilage at the micrometer range with high-sensitivity and high spatial
distribution [11,36,37]. Further details on confocal SR-μ-XRF can be
found elsewhere [38–42].
The present measurements have been carried out at the FLUO
beamline of the ANKA synchrotron facility at the Karlsruhe Institute of
Technology Campus North [40,41] applying the same confocal setup
as already described previously [32]. The actual excitation energy was
17 keV and the beam size was 17 μm × 12 μm (horizontal × vertical)
with a depth resolution of 19 μm at 9.71 keV (Au-Lα). Area scans in
the sample surface were performed in the range of 500 μm × 500 μm
up to 500 μm × 650 μm with a step size of 15 μm horizontal and
10 μm vertical. Acquisition times longer than 12 s per pixel were
found not to show any improvements in the signal to noise ratio of
the obtained elemental maps. Especially, the low levels of Pb content
required this relatively long acquisition time. The acquired spectra, an
example of which is shown in Fig. 1, were processed according to the
protocol described in [32].
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The information about bone tissue structure and mineral content
as obtained by qBEI was combined and correlated with the X-ray inten-
sities of the corresponding elementalmaps. The 2Ddata evaluation soft-
ware ImageJ (v1.44, National Institutes of Health, USA) [43] and custom
made routines were applied to pre-process the obtained data prior to
statistical evaluation with GraphPad Prism (v4.0c, GraphPad Software,
Inc., USA).
Regions of interest
First the qBEI images of high spatial resolution (1 μmper pixel) have
been alignedwith the corresponding SR μ-XRFmaps. Secondly, the ROIs
representing mineralized bone matrix and cement lines were indicated
in the qBEI images. ROIs of mineralized bonematrix weremarkedwith-
in single structural units (osteon, bone packet) taking care that at least a
distance of a fewmicrons (5 to 10 μm) to cracks, cement lines, osteocyte
lacunae, haversian canals or trabecular surface was kept. The cement
lines themselves were labeled by 10 μm thick lines corresponding the
X-ray beam diameter. Finally, these marks/masks in the qBEI image
were transferred/overlaid directly to the elemental maps (Fig. 2).
Normalization of SR μ-XRF-maps
A general normalization of the XRF count rates for acquisition time
and synchrotron-ring current of 100 mAwasperformed. TheXRF inten-
sities of Pb, Zn, and Srwere further corrected for variations in XRF inten-
sities caused by slight changes in the measurement setup between
different maps, samples and synchrotron sessions, so that the Pb, Zn,
and Sr XRF-intensities between all the maps can be directly compared
and treated asmeasures of elemental content. For this purpose an aver-
age factor K (see formula (1)) was evaluated for each map, expressing
the mean ratio between Ca as measured by qBEI (wt.% Ca) and Ca as
measured by SR μ-XRF(cpsCa). Thus, the multiplication of the SR
μ-XRF cps values of Pb, Zn, and Sr from the individual maps with the
corresponding K factors leads to a correction/normalization of all the
maps based on the absolute Ca values as obtained by qBEI method.
K ¼ 1
n
Xn
i¼1
wt:%Cai
cpsCai
ð1Þ
Formula 1: K = mean normalization factor of one SR μ-XRF map,
wt.%Cai = averaged Ca concentration of mineralized bone matrix ROIi
measured by qBEI, cpsCai = meanCa-Kα ﬂuorescence intensity ofmin-
eralized bone matrix ROIi, n = number of the mineralized bone matrix
ROIs of the respective map.Energ
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Fig. 1. SR μ-XRF spectrumof ameasurement point (pixel area) at a cement line. Acquisition time
Peaks not labeled: X-ray Kβ-lines, the scatter peaks (incoherent and coherent) and artiﬁcial peStatistical evaluation
For each sample themedians of the normalized count rates of Ca, Zn,
Pb and Sr for the mineralized bone matrix and the cement line ROIs
were calculated. The levels of signiﬁcance of the differences between
mineralized bone matrix and cement lines were tested with the non-
parametric Mann–Whitney test for each sample separately. For this
purpose all evaluated mineralized bone matrix and cement line ROIs
of the respective sample were used. The number of mineralized bone
matrix and cement line ROIs was different for all samples. The number
of cement line ROIs was larger for all samples. To evaluate the changes
in count rate ratios between cement lines and mineralized bone matrix
the Wilcoxon signed rank test with the hypothetical median value 1
(=equal elemental distribution) was used.
The signiﬁcance of the correlation between Ca content and trace ele-
ment levels of all evaluatedmineralized bonematrix ROIs of all samples
(n = 402) was tested with the non-parametric Spearman's test. Differ-
ences or correlations with p b 0.05 were considered signiﬁcant.
Results
It has to be emphasized that the spot size of the confocal SR μ-XRF
setup is about 5 times wider than the width of the cement lines. Thus
the levels of trace elements in the cement lines presented in the follow-
ing are actually a huge underestimate of the real levels of trace elements
(see details in “Limitations” section).
Maps of Zn, Pb and Sr in bone tissue
In Fig. 3 examples of spatial distribution/maps of the elements Ca,
Zn, Pb and Sr in bone tissue are demonstrated: i) the corresponding
qBEI images, a) osteonal and b) trabecular bone display regions with
different mineral content (dark gray, low and bright gray, high mineral
content). ii) None of the elemental XRFmaps show a homogeneous dis-
tribution within the bone tissue. iii) Zn exhibits a remarkable increase
in the cement lines and at the borders to the haversian channels (this
region was not evaluated). Zn intensities appear to be rather constant
in the mineralized bone matrix. This accumulation of Zn in the cement
lines is shown in Fig. 3b. The numerous parallel cement lines seen in
the qBEI image correspond with bands of high Zn-Kα intensities in
μ-XRF map. iv) Pb also accumulates in the cement lines and in the bor-
ders to the haversian channels (this region was not evaluated). More-
over Pb shows a strong correlation to the Ca-content in the
mineralized bonematrix. Thus, the central young osteon with lowmin-
eralization and therefore low Ca content has a very low Pb content that
even the detection limit of the SR-μ-XRF method is reached. In Fig. 3by [kev]
9 10 11 12 13 14 15 16 17
α
Pb-Lα
Sr-Kα
: 10 s; Fluorescence intensity: counts per second (cps) normalized to 100 mA ring current;
aks facts (sum and escape peaks).
qBEI Zn-Ka
qBEI Zn-Ka
2
1
2
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100 µm
Fig. 2.Method to deﬁne region of interest (ROI) for SR μ-XRFmaps evaluations: 1) Selection of a qBEI image e.g. of osteonal bone region (top-left) togetherwith the corresponding SR μ-XRF
map of Zn-Kα (top-right). 2) Identiﬁcation of homogeneous mineralized bone matrix, cement lines in the qBEI image and outlining them (bottom left): ROI #1 mineralized bone matrix
(yellow outlined areas) and ROI #2 cement lines (green lines 10 μm thick). 3) Transfer of the in the qBEI image marked ROIs to the SR-μ-XRF map (bottom-right).
187B. Pemmer et al. / Bone 57 (2013) 184–193the Pb levels of the bone samples are so low that the Pb maps exhibit
only a noise signal. v) The behavior of Sr distribution is different from
Zn and Pb. There is no accumulation at cement lines and haversian
channel borders. However there are distinctly visible differences be-
tween the mineralized bone matrix of the various osteons.
Comparison of Zn, Pb and Sr levels between mineralized bone matrix and
cement lines
In all investigated samples we found signiﬁcantly higher Zn and Pb
intensities in the cement lines compared to themineralized bonematrix
(Fig. 4) (p b 0.05 for each individual sample). Even in the sample, which
had the lowest Pb level (shown in Fig. 3b), a signiﬁcantly higher
Pb content in the cement lines could be found. There was a large
interindividual variation in Zn and Pb XRF intensities of mineralized
bone matrix and cement lines (Fig. 4).
When analyzing the cement line to mineralized bone matrix ratios
for Zn and Pb (Fig. 5) of all samples we found the following: i) Zn con-
tentwas inmedian1.3 times higher (lower quartile: 1.2; upper quartile:
1.4; p b 0.05) in cement line than in mineralized bone matrix; ii) Pb
levels were inmedian 2.0 times higher (lower quartile: 1.5; upper quar-
tile: 2.5; p b 0.05) in the cement line than in mineralized bone matrix;
in one sample Pb was 3.8 times increased compared to the mineralized
bone matrix (Fig. 5). Thus, we found greater interindividual differences
for Pb than for Zn.
In contrast, Sr intensities were not signiﬁcantly changed between
mineralized bone matrix and cement lines.
Relationship of the mineralization on Zn, Pb and Sr levels in mineralized
bone matrix
The correlation of Ca content and trace element levels was evaluated
using data obtained from all mineralized bone matrix ROIs (yellowlabeled regions in Fig. 2) of all samples. Diagrams showing the relation-
ships of Zn, Pb and Sr to the Ca content are presented in Fig. 6. No corre-
lations between Zn and Ca levels were found, while Pb and Sr showed
a non-linear increase with the degree of mineralization, which was
signiﬁcant (p b 0.001; Spearman's rank correlation test).
Comparison between fractured and non-fractured femoral necks
The analysis of the data from the two subgroups, femoral neck bone
with an osteoporotic neck fracture and age matched without fracture,
revealed no signiﬁcant differences in the trace element content and
distribution pattern.
Discussion
Synchrotron radiation induced confocal micro X-ray ﬂuorescence
analysis (SR μ-XRF) together with quantitative backscattered electron
imaging (qBEI) have been used for the ﬁrst time to evaluate the spatial
distribution of the trace elements Zn, Sr and Pb in bone tissue. The anal-
ysis revealed a higher level of Zn and Pb in the cement lines compared to
the adjacent mineralized bone matrix. In the bone packets/osteons
levels of Pb and Sr were signiﬁcantly dependent on their Ca content.
In contrast, this was not found for Zn.
Mineralized bone matrix versus cement lines
The cement lines as identiﬁed and traced in the qBEI images
show consistently higher Zn and Pb values compared to the adjacent
mineralized bone matrix indicating a different mechanism of Zn and
Pb incorporation/accumulation between these two regions of bone tis-
sue. In contrast to the mineralized bone matrix the cement line (more
precise cement surface) is rich with non-collagenous proteins like
osteocalcin and osteopontin [27]. During the reversal phase of bone
Ca-Ka 59043
54
Zn-Ka 799
15
qBEI
b) Pb-La 2
0
Sr-Ka 67
0
Ca-Ka 85133
970
Zn-Ka 2083
20
Pb-La 73
0
Sr-Ka 286
0
qBEI
a)
100 µm
100 µm
Fig. 3. Examples of qBEI imageswith corresponding SR μ-XRF elementmaps of Ca, Zn, Pb, Sr: (a) osteonal bone region of the human femoral neck (b) cancellous bone region of the human
femoral neck. The color-coded X-ray intensities are normalized to counts per second (cps), 100 mA Ring current and are scaled fromminimum tomaximumwithin each individual map.
qBEI images show younger bone packets (less mineralized) as darker, and older bone packets (more mineralized) as brighter gray levels. Sample (b) exhibiting multiple parallel cement
lines.
188 B. Pemmer et al. / Bone 57 (2013) 184–193remodeling the cement line is formed, which getsmineralized in gener-
al to a higher extent than the adjacentmineralized bonematrix as visu-
alized by backscattered electron imaging. This cement surface layer is
exposed to the interstitial ﬂuid until the new bone matrix (osteoid) is
deposited by the osteoblasts. During this period Zn and Pb ions present
in the interstitial ﬂuid can be accumulated in the deposited cement line
material (proteins and mineral) in two ways: a) by uptake of the ions
directly in hydroxyapatite and additionally b) by attachment to pro-
teins, which have a high afﬁnity to them. Thus, the increased Pb concen-
trations in the cement lines may be due to the osteocalcin, which has a
higher afﬁnity to Pb than to Ca even at low Pb levels [44,45]. In contrast,
Zn is part/cofactor of enzymes like matrix metalloproteinases (MMPs)
which are playing an important role in degradation of collagen during
the remodeling cycle of bone [46] as well as bone alkaline phosphatase
[b-ALP] [47–51]. All synthesized osteoblasts are involved also in the
bone matrix mineralization. This increase in Zn levels of the cement
line suggests that these enzymes/proteins are stored in the cement
lines during the remodeling process. It can be speculated that in a fol-
lowing bone resorption phase the Zn ions are released and again used
as cofactor of the enzymes for the subsequent bone formation phase
and/or immediately incorporated back into the new formed bone. Thisis supported by the fact that during bone remodeling Zn is not increas-
ing the serum levels [52–54].
Interestingly, the inter-individual variations of Zn levels are far
smaller compared to Pb (Fig. 4a), which suggests that Zn is an inherent
component of the cement line rather than dependent of the variations
of the period where the cement line is exposed to the interstitial ﬂuid
during the remodeling cycle as Pb obviously does. In this context it
had to be mentioned that in recent studies regarding the Zn levels
observed in the transition zone between mineralized and non-
mineralized cartilage (tide mark), a similar differential behavior of Zn
and Pb accumulation was found. Zn was distinctly increased without
major variations too, while the coincident increase of Pb was higher
the longer the tide mark was exposed to the interstitial ﬂuid of the
non-mineralized articular cartilage [11,12,36].
In contrast to Zn and Pb, Sr has no accumulation phenomenon in the
cement lines that can be observed, though it is well known that Sr+2
ions are able to substitute Ca+2 ions. Animal studies suggest that Sr
can substitute Ca in almost any physiological process and is almost ex-
clusively deposited in bone [55]. Theprotein binding afﬁnity of Sr is sim-
ilar to that of Ca [56]. The dietary amount of Sr can vary widely without
occurrence of symptoms of intoxication and it is not under homeostatic
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Fig. 4.Differential accumulation of Zn and Pb inmineralized bonematrix and cement lines
in femoral head and neck samples in the osteonal as well as in the cancellous bone region.
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concentration ratios of Zn, Pb and Sr between cement lines and mineralized bone matrix.
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189B. Pemmer et al. / Bone 57 (2013) 184–193control so the blood and serum levels are not kept constant [55]. As it
will be elaborated in the limitations below, there might be a coincident
increase of Sr with Ca in the cement line, but the relative increase in Ca
and Sr is likely too small to be distinguished in amatrix volumeof 12 μm
(voxel size) with a cement line thickness of only 1 to 2 μm.
Trace element vs mineralized bone matrix Ca content
Within a BSU the trace elements are uniformly distributed similar to
the element Ca. Our hypothesizedmechanismof trace element incorpo-
ration is therefore, that Zn, Sr and Pb are incorporated into the bone
mineral (carbonated calcium hydroxyapatite) during bone formation,
when the osteoid gets mineralized by progression of the mineralization
front (primary mineralization phase) [26]. The amount of the incorpo-
rated trace elements is thereby dependent on the serum levels present.This assumption is strongly supported by the studies we made on Sr
incorporation in bone during Sr-ranelate treatments (human and ani-
mals [32,57,58]). It could be shown that Sr was incorporated mainly in
mineralized bone matrix, which was formed during Sr ranelate treat-
ment. Further, the Sr content was proportional to the Sr serum levels
[57]. Moreover, the analysis of the mineral crystal lattice characteristics
proved that the Sr ion was incorporated into the apatite crystal lattice
[58].
The Pb present in the mineralized bone matrix is most likely accu-
mulated during the mineralization phase similar to Sr. Pb2+ ions in
the serum are chemically similar to Ca2+ ions. It has been even demon-
strated that Pb2+ is directly competingwith Ca2+ at the voltage activat-
ed Ca2+ channels [59,60]. Further it has been shown that Pb2+ is able to
occupy both Ca2+ sites in the hydroxyapatite (HA) crystal [61–64]. A
similar behavior was suggested for Sr2+ ions [55,58]. We assume that
as for Sr [57,58,65–68] the amount of Pb incorporated during theminer-
alization depends on the Pb serum levels. Themore Pb2+ ions present in
the serum the more Pb ions are incorporated into the bone.
Moreover, in-vitro studies using synthetic HA aswell as bovine bone
meal found that HA has the ability to accumulate (immobilize) Pb2+,
Zn2+, Sr2+ and other divalent metal ions [69–76]. At the moment four
different pathways are suggested for the immobilization mechanisms
of HA: i) ion exchange process, ii) surface complexation, iii) dissolution
and precipitation and co-precipitation [69]. These mechanisms can be
expected to be very similar for the other divalent ions. In these studies
rather high concentrations of the heavymetals have been used. Howev-
er according to Bigi et al. [77] and Bückner et al. [78] it is likely that the
accumulation mechanisms of HA for Pb2+ are also valid at low concen-
trations, as they are present in humans. For Pb in bone we have shown
that it almost exclusively bonds to carbonated calcium hydroxyapatite
[79], which conﬁrms the above assumptions on how Pb is incorporated
into the mineralized bone matrix.
Interestingly, despite high intra- and inter-individual variations
in Pb (Fig. 4b) and Sr levels, a non-linear increase with Ca-content
of the mineralized bone matrix was found (Figs. 6b and c). The over-
proportional increase of Pb and Sr at the high mineralization range
may be explained by the fact that BSUs with prolonged time of mineral-
ization (secondary mineralization phase) reach a plateau of mineraliza-
tion (about 26 wt.% Ca) [26]. However, accumulation processes, as
already stated above, of Pb2+ and Sr2+ ions in the apatite crystals may
be still ongoing with time, after the crystals had stopped growing by
ion substitution. Sr2+, Pb2+ and presumably all other divalent metal
ions might reach the inner parts of the bone through the vascular
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Fig. 6.Correlations between Ca content and levels of the trace elements Zn, Pb and Sr in the
mineralized bone matrix of the femoral neck and the femoral head samples. X-axis: Ca
wt.% as obtained by qBEI. Y-axis: Normalized X-ray intensities using formula (1). The
displayed values/data points correspond to all mineralized bone matrix ROIs obtained
from all analyzed maps. One data point represents one mineralized bone matrix ROI.
Spearman's rank correlation test: R — correlation coefﬁcient, p-value signiﬁcant for
p b 0.05, number of pairs: n = 402.
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An animal study using radiostrontium (85Sr) showed that the Sr2+ ions
pass through thewall of the vascular capillaries by diffusion to reach the
interstitial ﬂuids [80]. The same way can be assumed for Pb2+ ions.
From the bone marrow space the osteocyte lacunae canaliculi network
might be used as pathway for Pb2+ and Sr2+ into the mineralized
bone matrix, resulting in the observed overproportional increase of
these elements compared to Ca.
Though it has been reported that Zn is concomitantly incorporated
with Ca during the mineralization [81], no correlation between Zn and
the degree ofmineralization like for Sr and Pbwas detected by ourmea-
surements (Fig. 6a). This is in agreement with prior investigations of
Lappalainen et al., who showed that Ca is not a signiﬁcant factor for
explaining the Zn concentrations in bone [82]. Therefore Zn is suggested
to be under homeostatic control.
Zn bond to hydroxyapatite (HA) is very likely incorporated during
the fast crystallization process as experiments of Tang et al. in 2009
have shown [83]. However the preference coordination site of Zn, the
Ca2 site of the HA crystal, would allow the uptake and release of Zn as
the Ca2 site framework of the structure is not disrupted [83]. Zn2+ is
not simply incorporated by ion exchange processes, but Ca2+
vacancy-defects can act as plausible sites for Zn2+ substitution [84]. As
said above, Zn is essential for bone metabolism, as it is part of enzymes
important for the remodeling mechanisms of bone and the Zn released
during bone remodeling is incorporated back into the bone [46,50,52].Limitations
The matching of qBEI images with μ-XRF obtained elemental maps
could not be perfectly performed. The different lateral resolutions of
SR μ-XRF (~10–20 μm) and of qBEI (1–2 μm) make an exact overlay of
both maps impossible. Thin features (e.g. cement lines) in the qBEI are
blurred in the μ-XRF maps. Furthermore the larger information depth
of SR μ-XRF (~20 μm for Ca-Kα) compared to qBEI (~1 μm) contributes
to further blurring. Features close below the surface (e.g. cement lines,
or cavities/voids) are not detected by qBEI but might be visible in the
corresponding μ-XRF maps. However, superimposing the correspond-
ing SR μ-XRF elementalmaps and BE imageswas found to be very useful
in linking bone morphology with X-ray intensities.
An underestimation of Zn and Pb signal intensities in the cement
lines is introduced due to the fact that the cement lines are much thin-
ner (in the range of 2 μm) than the focused X-ray beamwidth. The XRF
signal is averaged over a larger matrix volume than the true cement
line feature occupies. Hence the obtained data shows a lower limit for
the real relative elemental concentration. Assuming a SR μ-XRF voxel
size of 12 × 13 × 17 μm3 and a cement line of width of 1 μm a 2-fold
increase in Pb level in the cement line as measured by μ-XRF might be
the result of an actual 34-fold increase.
To determine the signal intensity ratios of Zn and Pb between
cement lines and mineralized bone matrix and to further investigate
their spatial distributionwithin the cement line scans or evenmappings
at nano focus beam lines such as P06 at PETRA III (DESY, Hamburg,
Germany) are planned for the future.
No absolute values (wt.%) of Zn, Pb and Sr can be given. Thus, only
relative differences between the elements could be reported. Since
bone is a complex and highly heterogeneous organicmineral compound,
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mental setup available, which would have allowed obtaining the abso-
lute concentrations of trace elements corresponding to each measured
X-ray count rates.Implications
The incorporated Pb, Zn and Sr ions in HAwill most likely distort the
crystal lattice of themineral due to the different atomic sizes compared
to Ca. This might have negative effects on the stability and strength of
the mineral. These effects can probably become relevant at high incor-
poration levels. However, a 5% replacement of Ca ions by Sr ions occurs
in Sr ranelate treatment in postmenopausal osteoporosis [57,58]. The
changes in mechanical properties of bone material as measured by
nanoindentation could not be observed [57].
The highly toxic effects of Pb on bone cells and bonemetabolism and
thus bone remodeling are described in detail for high Pb levels of whole
body exposure [44,45,60,63,85]. For example, Pb has been shown to
alter the Ca homeostasis and perturb the cellular metabolism or activity
of osteoclasts [86] and osteoblasts [87–92]. As already stated Pb2+ has a
muchhigher afﬁnity to osteocalcin than Ca2+ [45] and as a consequence
Pb2+ inﬂuences the binding properties of osteocalcin to the bone
minerals negatively [44]. We can speculate that, in principle, the same
mechanisms take effect locally, though to a much lower extent, when
Pb ions were released in the interstitial ﬂuid during bone remodeling
with a normal bone turnover rate. However, the release of Pb stored
in the bone can strongly be enhanced in diseases with increased bone
turnover.
Medical conditions or diseases, such as osteoporosis, hyperthyroid-
ism, hyperparathyroidismandpregnancy cause an increased bone turn-
over and are accordingly linkedwith elevated release of Pb immobilized
and stored in the skeleton [22,93,94]. The remobilization of bone Pb
back into the circulation is a potentially relevant source of soft-tissue
Pb exposure and toxicity long after the external Pb exposure ceased
[95]. The Pb in serum may increase to levels which are possibly toxic
for inner organs (e.g. the nervous and the hematopoietic system) that
are more sensitive to Pb and other heavy metals. Even metabolic pro-
cesses in the bone are adversely affected by Pb [44,45,60,63,85]. Further
Pb has been stated as a potential risk factor for osteoporosis [23], has
negative inﬂuences on bone healing mechanisms [96] and might
affect the articular cartilage tissue [24]. In the present study no signiﬁ-
cant differences in the trace element content and distribution pattern
between bones from individuals with osteoporotic neck fractures and
those from age matched healthy individuals without fractures could
be detected. However, the sample size was only n = 5.
The main sources of Pb exposure in industrialized countries are
derived in the past from leaded water pipes and leaded gasoline.
Much effort has been taken to eliminate almost all of these sources
[21]. However, the biological half-life of Pb in human bone is about
20 years [97,98]. Thus the bone analyzed from individuals in the age
range of 60 to 80 years still had measurable amounts of Pb present. It
would be interesting to know how much the environmental Pb uptake
is reduced now in young people.Conclusions
We have shown for the ﬁrst time that the distribution of the trace
elements Zn, Pb and Sr is not uniform among the structural units of
human bone tissues, applying a combination of SR μ-XRF and qBEI.
Further cement lines are accumulating Zn and Pb to higher levels than
adjacent mineralized bone matrix indicating a possibly different mech-
anism of Zn, Sr, and Pb uptake. Additionally, it was revealed that in bone
structural units the concentration of Pb and Sr depends on the degree of
mineralization while this was not the case for Zn.Author contributions
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